Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
05/13/20218:30AMPR Newswire (US)Study of DSUVIA® Showing Significant Reduction in Postoperative Opioids and Better OBAS Scores Compared to Control Group to ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/10/20214:05PMPR Newswire (US)AcelRx to Host First Quarter 2021 Financial Results Call and Webcast on May 17, 2021NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/06/20218:30AMPR Newswire (US)AcelRx Announces an Investigator-Initiated Study of DSUVIA® for Use in Same-Day Total Joint ReplacementNASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/27/20214:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/23/20219:31AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/23/20219:29AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/08/20218:30AMPR Newswire (US)AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical Procedur...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/31/20215:20PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/31/20218:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of DirectorsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/25/20218:30AMPR Newswire (US)AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Fo...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/22/20212:48PMPR Newswire (US)AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/15/20215:29PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/15/20214:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/15/20214:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/09/20215:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/08/20214:05PMPR Newswire (US)AcelRx to Host Fourth Quarter and Full Year 2020 Financial Results Call and Webcast on March 15, 2021NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/05/20213:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/05/20213:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/05/20213:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/05/20213:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/17/20218:30AMPR Newswire (US)AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Plastic Surgery ProceduresNASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/12/20216:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/12/20216:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/12/20216:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/10/20212:59PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/09/20214:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/09/20214:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/09/20214:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/29/20216:02AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
01/21/20215:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX